Aurinia Pharmaceuticals Inc (AUPH)

[CoolG73]

Regarding Safety, I am not expecting any Death this time in Asia since half of the Study sites are in Japan and South Korea. the other half is in countries that were used in AURA and didn't show any safety issues (except Philippine where the number of sites was reduced from 8 in AURA to 5 AURORA ,to remove the sites that had dead patients in AURA). Glad to see management taking mitigation action in this regard. Some patients in LAtin America sites could die depending on how sick they are and how thorough they follow their AEs , especially early in the trial.
but overall, I am expecting the number of dead patients to be reduced substantially with Asia now less risky than as it was in AURA trial.